Dezerv

Fund Overview

Fund Size

Fund Size

₹2,794 Cr

Expense Ratio

Expense Ratio

0.48%

ISIN

ISIN

INF769K01ED6

Minimum SIP

Minimum SIP

₹1,000

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

02 Jun 2018

About this fund

Mirae Asset Healthcare Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by Mirae Asset India Mutual Fund. This fund has been in existence for 6 years, 4 months and 29 days, having been launched on 02-Jun-18.
As of 30-Oct-24, it has a Net Asset Value (NAV) of ₹41.87, Assets Under Management (AUM) of 2793.61 Crores, and an expense ratio of 0.48%.
  • Mirae Asset Healthcare Fund Direct Growth has given a CAGR return of 25.02% since inception.
  • The fund's asset allocation comprises around 99.64% in equities, 0.00% in debts, and 0.35% in cash & cash equivalents.
  • You can start investing in Mirae Asset Healthcare Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+54.01%

+55.55% (Cat Avg.)

3 Years

+20.48%

+19.48% (Cat Avg.)

5 Years

+31.16%

+27.86% (Cat Avg.)

Since Inception

+25.02%

(Cat Avg.)

Portfolio Summaryas of 30th September 2024

Equity2,783.64 Cr99.64%
Others9.97 Cr0.36%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Sun Pharmaceuticals Industries LtdEquity346.31 Cr12.40%
Aurobindo Pharma LtdEquity233.14 Cr8.35%
Cipla LtdEquity196.01 Cr7.02%
Dr Reddy's Laboratories LtdEquity177.56 Cr6.36%
Apollo Hospitals Enterprise LtdEquity164.43 Cr5.89%
Glenmark Pharmaceuticals LtdEquity154.32 Cr5.52%
Lupin LtdEquity141.57 Cr5.07%
Divi's Laboratories LtdEquity127.05 Cr4.55%
Gland Pharma LtdEquity119.06 Cr4.26%
Krishna Institute of Medical Sciences LtdEquity111.85 Cr4.00%
Torrent Pharmaceuticals LtdEquity102.79 Cr3.68%
Suven Pharmaceuticals LtdEquity100.12 Cr3.58%
Syngene International LtdEquity86.34 Cr3.09%
Mankind Pharma LtdEquity79.92 Cr2.86%
J.B. Chemicals & Pharmaceuticals LtdEquity76.97 Cr2.76%
Fortis Healthcare LtdEquity71.9 Cr2.57%
Zydus Lifesciences LtdEquity61.27 Cr2.19%
Strides Pharma Science LtdEquity60.48 Cr2.17%
Alkem Laboratories LtdEquity60.27 Cr2.16%
Ipca Laboratories LtdEquity49.37 Cr1.77%
Wockhardt LtdEquity47.31 Cr1.69%
Dr. Lal PathLabs LtdEquity39.06 Cr1.40%
Emcure Pharmaceuticals LtdEquity28.76 Cr1.03%
Biocon LtdEquity27.74 Cr0.99%
Max Healthcare Institute Ltd Ordinary SharesEquity26.62 Cr0.95%
Neogen Chemicals LtdEquity21.28 Cr0.76%
Sanofi India LtdEquity18.9 Cr0.68%
Ajanta Pharma LtdEquity14.75 Cr0.53%
Sanofi Consumer Healthcare India LtdEquity13.53 Cr0.48%
SRF LtdEquity12.57 Cr0.45%
TrepsCash - Repurchase Agreement12.54 Cr0.45%
Natco Pharma LtdEquity12.4 Cr0.44%
Net Receivables / (Payables)Cash-2.79 Cr0.10%
Mirae Asset Liquid Dir GrMutual Fund - Open End0.22 Cr0.01%

Allocation By Market Cap (Equity)

Large Cap Stocks

44.94%

Mid Cap Stocks

35.71%

Small Cap Stocks

17.48%

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare2,749.8 Cr98.43%
Basic Materials33.84 Cr1.21%

Risk & Performance Ratios

Standard Deviation

This fund

16.01%

Cat. avg.

15.87%

Lower the better

Sharpe Ratio

This fund

0.86

Cat. avg.

0.85

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.55

Higher the better

Fund Managers

Vrijesh Kasera

Vrijesh Kasera

Since July 2018

Additional Scheme Detailsas of 30th September 2024

ISIN
INF769K01ED6
Expense Ratio
0.48%
Exit Load
1.00%
Fund Size
₹2,794 Cr
Age
6 years 4 months
Lumpsum Minimum
₹5,000
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹21.04 Cr57.8%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

0.9%1.0%₹888.27 Cr52.1%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹888.27 Cr50.0%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹39.61 Cr53.9%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹201.94 Cr59.4%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹201.94 Cr56.4%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2793.61 Cr54.0%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

1.9%1.0%₹2793.61 Cr51.7%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹851.53 Cr52.0%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹19.51 Cr52.8%

About the AMC

Mirae Asset India Mutual Fund

Mirae Asset India Mutual Fund

Total AUM

₹1,97,338 Cr

Address

Unit No. 606, 6th Floor, Mumbai, 400 098

Other Funds by Mirae Asset India Mutual Fund

Fund nameExpense RatioExit LoadFund size
1Y
Mirae Asset Multi Asset Allocation Fund Direct Growth

High Risk

0.4%1.0%₹1704.72 Cr-
Mirae Asset Great Consumer Fund Direct Growth

Very High Risk

0.4%1.0%₹4496.23 Cr37.8%
Mirae Asset Cash Management Direct Growth

Low to Moderate Risk

0.1%0.0%₹10348.55 Cr7.5%
Mirae Asset Emerging Bluechip Direct Growth

Very High Risk

0.6%1.0%₹40670.04 Cr35.0%
Mirae Asset Large Cap Fund Direct Growth

Very High Risk

0.5%1.0%₹42179.27 Cr28.9%
Mirae Asset Savings Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹1150.94 Cr8.1%
Mirae Asset Money Market Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹1533.62 Cr7.9%
Mirae Asset Focused Fund Direct Growth

Very High Risk

0.6%1.0%₹8653.39 Cr30.0%
Mirae Asset Dynamic Bond Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹138.54 Cr8.6%
Mirae Asset NYSE FANG+ ETF Fund of Fund Direct Growth

Very High Risk

0.7%0.0%₹1462.42 Cr65.1%
Mirae Asset Hybrid Equity Fund Direct Growth

Very High Risk

0.4%1.0%₹9481.01 Cr28.3%
Mirae Asset Equity Allocator Fund of Fund Direct Growth

Very High Risk

0.2%0.0%₹896.97 Cr35.0%
Mirae Asset Nifty 100 ESG Sector Leaders Fund of Fund Direct Growth

Very High Risk

0.6%0.0%₹110.61 Cr31.1%
Mirae Asset S&P 500 Top 50 ETF Fund of Fund Direct Growth

Very High Risk

0.7%0.0%₹536.14 Cr43.9%
Mirae Asset Nifty SDL Jun 2027 Index Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹759.41 Cr9.2%
Mirae Asset Ultra Short Duration Fund Direct Growth

Low to Moderate Risk

0.2%0.0%₹1458.90 Cr7.9%
Mirae Asset Flexi Cap Fund Direct Growth

Very High Risk

0.5%1.0%₹2384.26 Cr33.0%
Mirae Asset Banking and Financial Services Fund Direct Growth

Very High Risk

0.6%1.0%₹1882.18 Cr27.7%
Mirae Asset Multicap Fund Direct Growth

Very High Risk

0.4%1.0%₹3473.13 Cr38.0%
Mirae Asset Nifty India Manufacturing ETF Fund of Fund Direct Growth

Very High Risk

0.5%0.0%₹121.28 Cr49.9%
Mirae Asset Tax Saver Fund Direct Growth

Very High Risk

0.6%0.0%₹26417.64 Cr36.2%
Mirae Asset Nifty SDL Jun 2028 Index Fund Direct Growth

Moderate Risk

0.1%0.0%₹69.12 Cr9.6%
Mirae Asset Corporate Bond Fund Direct Growth

Moderate Risk

0.2%0.0%₹43.00 Cr8.6%
Mirae Asset Hang Seng TECH ETF Fund of Fund Direct Growth

Very High Risk

0.7%0.0%₹87.85 Cr45.0%
Mirae Asset Equity Savings Fund Direct Growth

Moderately High risk

0.3%1.0%₹1324.70 Cr18.7%
Mirae Asset Banking and PSU Debt Fund Direct Growth

Moderate Risk

0.4%0.0%₹55.77 Cr8.6%
Mirae Asset Global X Artificial Intelligence & Technology ETF Fund of Fund Direct Growth

Very High Risk

0.9%1.0%₹316.79 Cr48.7%
Mirae Asset Global Electric & Autonomous Vehicles ETFs Fund of Fund Direct Growth

Very High Risk

2.0%1.0%₹65.07 Cr10.8%
Mirae Asset Overnight Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹989.35 Cr6.8%
Mirae Asset Short Term Fund Direct Growth

Low to Moderate Risk

0.3%0.0%₹341.86 Cr8.7%
Mirae Asset CRISIL IBX Gilt Index - April 2033 Index Fund Direct Growth

Moderate Risk

0.1%0.0%₹262.70 Cr11.0%
Mirae Asset Nifty AAA PSU Bond Plus SDL Apr 2026 50:50 Index Fund Direct Growth

Low to Moderate Risk

0.1%0.0%₹88.51 Cr8.1%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2793.61 Cr54.0%
Mirae Asset Arbitrage Fund Direct Growth

Low Risk

0.2%0.0%₹2772.50 Cr8.2%
Mirae Asset Midcap Fund Direct Growth

Very High Risk

0.6%1.0%₹17787.87 Cr39.7%
Mirae Asset Balanced Advantage Fund Direct Growth

High Risk

0.7%1.0%₹1770.05 Cr21.8%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of Mirae Asset Healthcare Fund Direct Growth, as of 30-Oct-2024, is ₹41.87.
The fund has generated 54.01% over the last 1 year and 20.48% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.
The fund's allocation of assets is distributed as 99.64% in equities, 0.00% in bonds, and 0.35% in cash and cash equivalents.
The fund managers responsible for Mirae Asset Healthcare Fund Direct Growth are:-
  1. Vrijesh Kasera